Individual and combined effects of mesenchymal stromal cells and recombinant stimulatory cytokines on the in vitro growth of primitive hematopoietic cells from human umbilical cord blood

Cytotherapy

Volumn 11, Issue 7, 2009, Pages 886-896

  Flores Guzmn, Patricia ^a   Flores Figueroa, Eugenia ^a   Montesinos, Juan J ^a   Martnez Jaramillo, Guadalupe ^a   Fernndez Snchez, Veronica ^a   Valencia Plata, Ignacio ^a   Alarcn Santos, Guadalupe ^b   Mayani, Hector ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Cell expansion; Cell proliferation; Cytokines; Hematopoietic progenitors; In vitro; Mesenchymal stromal cells

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; ERYTHROPOIETIN; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; RECOMBINANT CYTOKINE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR; THROMBOPOIETIN;

ARTICLE; BONE MARROW; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL SELECTION; CELL STIMULATION; CELL SUBPOPULATION; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MESENCHYME CELL; PRIORITY JOURNAL; STROMA CELL; UMBILICAL CORD BLOOD;

EID: 70450180831     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653240903180076     Document Type: Article

References (37)

1. Butler AC, Fitzsimons EJ, Graham GJ. Ex vivo expansion of cord blood cells: the clinical potential. In: Cohen SBA, Gluckman E, Rubinstein P, Madrigal JA. Cord Blood Characteristics, UK: Martin Dunitz; 2000. p. 169-203.
2. Miller CL, Audet J, Eaves CJ. Ex vivo expansion of human and murine hematopoietic stem cells. In: Klug CA, Jordan CT. Hematopoietic Stem Cell Protocols. USA: Humana Press; 2002. p. 189-208.
3. Haylock DN, Nilsson SK. Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther 2007;2:324-335.
4. Douay L. Experimental culture conditions are critical for the ex vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 2001;10:341-346.
5. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-2653.
6. Mayani H, Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998;16:153-165.
7. Pecora AL. Progress in clinical applications of progenitor cells expanded with hematopoietic growth factors. Curr Opin Hematol 2001;8:142-148.
8. Prince HM, Simmons PJ, Whitty G, Wall D, Barber L, Toner GC, et al. Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol 2004;126:536-5.
9. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood cells. Biol Blood Marrow Transplant. 2002;8:368-376.
10. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex two-expanded UCB cells: results of a phase I trial using the Aastrom-Replicell System. Blood 2003;101:5061-5067.
11. Mayani H, Guilbert LJ, Janowska-Wieczorek A Biology of the hemopoietic microenvironment. Eur J Haematol 1992;49:225-233.
12. Charbord P. Microenvironmental cell populations essential for the support of hematopoietic stem cells. In: Zon LI. Hematopoiesis. USA Oxford University Press; 2001. p. 691-701.
13. Scadden DT. The stem cell niche as an entity of action. Nature 2006;441:1075-1079.
14. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:836-841.
15. Dazzi F, Ramasamy R, Glennie S, Jones SP, Roberts I. The role of mesenchymal stem cells in haematopoiesis. Blood Rev 2006;20:161-171.
16. McNiece I, Harrington J, Turney J, et al. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 2004;6:311-317.
17. Rosier E, Brandt J, Chute J, Hoffman R. Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells. Exp Hematol 2000;28:841-852.
18. Fei XM, Wu YJ, Chang Z, et al. Co-culture of cord blood CD34+cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice. Cytotherapy 2007;9:338-347.
19. Hutton JF, Rosenkov V, Khor FSL, D'Andrea RJ, Lewis ID. Bone morphogenetic protein 4 contributes to the maintenance of primitive cord blood hematopoietic progenitors in an ex vivo stroma-noncontact co-culture system. Stem Cells Dev 2006;15:805-813.
20. Ando K, Nakamura Y, Chargui J, et al. Extensive generation of human cord blood CD34+stem cells from Lin" CD34" cells in a long-term in vitro system. Exp Hematol 2000;28:690-699.
21. Magin AS, Korfer N, Partenheimer H, Lange C, Zander A, Noll T. Primary cells as feeder cells for coculture expansion of human hematopoietic stem cells from umbilical cord blood: a comparative study. Stem Cells Dev 2009;18:173-186.
22. Flores-Guzman P, Flores-Figueroa E, Martinez-Jaramillo G, Mayani H. In vitro characterization of two lineage-negative CD34+cell-enriched hematopoietic cell populations from human UC blood. Cytotherapy 2005;7:334-344.
23. Flores-Guzman P, Gutierrez-Rodriguez M, Mayani H. In vitro proliferation, expansion and differentiation of a CD34+cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines.Arch Med Res 2002;33:107-114.
24. Flores-Guzman P, Martinez-Jaramillo G, Mayani H. Growth kinetics of progenitor cell-enriched hematopoietic cell populations in long-term liquid cultures under continuous removal of mature cells. Cytotherapy 2006;8:299-307.
25. Wognum AW, Eaves AC, Thomas TE. Identification and isolation of hematopoietic stem cells. Arch Med Res 2003;34:461-475.
26. Flores-Figueroa E, Arana-Trejo RM, Gutierrez-Espindola G, Perez-Cabrera A, Mayani H. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 2005;29:215-224.
27. Flores-Figueroa E, Montesinos JJ, Flores-Guzman P, et al. Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells. Leuk Res 2008;32:1407-1416.
28. Sutherland HJ, Eaves CJ. Long-term culture of human myeloid cells. In: Freshney RI, Pragnell IB, Freshney MG. Culture of Hematopoietic Cells. USA; Wiley-Liss; 1994. p. 139-162.
29. Miller CL, Eaves CJ. Long-term culture initiating-cell assays for human and murine cells. In: Klug CA, Jordan CT. Hematopoietic Stem Cell Protocols. USA; Humana Press; 2002. p. 123-141.
30. Wang J-F, Wang L-J, Wu Y-F, et al. Mesenchymal stem/ progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34+ hematopoietic stem cells and for chondrogenic differentiation. Haematologica 2004;89:837-844.
31. Xie C-G, Wang J-F, XiangY, etal. Cocultivation of umbilical cord blood CD34+ cells with retro-transduced hMSC leads to effective amplification of long-term culture initiating cells. World J Gastroenterol 2006;21:393-402.
32. Wagner W, Roderburg C, Wein F, et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 2007;25:2638-2647.
33. Jang YK, Jung DH, Jung MH, et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 2006;85:212-225.
34. Metcalf D. Hematopoietic cytokines. Blood. 2008;111: 485-491.
35. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. Human bone marrow CD34" cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+cells. Exp Hematol 1998;26:353-360.
36. Bathia M, Bonnet D, Murdoch B, Gan OI, Dick J. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998;4:1038-1045.
37. Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bathia M. Isolation and characterization of human CD34" Lin" and CD34+ Lin" hematopoietic stem cells using cell surface markers AC133 and CW. Blood 2000;95:2813-2820.